Atlas Trials

Comparison of Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Cancer Breakthrough Pain (FT-019-IM)

Clinical trial NCT00496392 · COMPLETED

Trial details

NCT number
NCT00496392
Sponsor
Nycomed
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pain
Start date
2007-01-01
Primary completion
2008-08-01
Enrollment
115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.